Account
Newsletter
15.03.2023
PMA Insights: Week 11

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
22.02.2023
What are the risks and benefits of Early Access Pr...

Using Early Access Programs (EAPs) to give patients with life threatening conditions access to medic...

Read more
Newsletter
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Introduction Real World Data is being increasingly used across the globe to support medical-product ...

Read more
Insider Insights
14.07.2022
HRA pharma bids to bring first OTC contraceptive p

Access to birth control is more important than ever after Roe v Wade was struck down, amid reports t...

Read more
Insider Insights
23.06.2022
NICE publish their new real world evidence framewo

NICE have been clear that this framework should not be interpreted as minimum standards for real-wor...

Read more
Insider Insights
09.06.2022
UK launch of innovative medicines fund

Through the new fund, £340 million is to be made available to purchase promising, potentially life-...

Read more
Insider Insights
26.05.2022
G-BA awards highest rating to Trodelvy

The drug was judged to offer an indication of major additional benefit in adult patients with advanc...

Read more
Insider Insights
04.05.2022
The European Health Data Space launch

The EHDS will integrate three main product markets for primary use of health data: electronic health...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.